Biotech & Pharma press releases

70 releases

Akeso, Inc.1h ago

Ivonescimab Receives NMPA Priority Review for First-Line Biliary Tract Cancer

Akeso, Inc. (HKEX: 9926.HK) today announced that ivonescimab in combination with chemotherapy for the first-line treatment of locally advanced or…

National University Hospital (NUH)5h ago

ONE OF THE WORLD'S FIRST PERSONALISED BRAIN STIMULATION STUDIES SHOWS PROMISE FOR SEVERE OCD WITH NUH AND NUS MEDICINE EXTENDING THE APPROACH TO DEPRESSION AND ANXIETY

Building on an established NUH–NUS Medicine collaboration, the work combines clinical expertise and cutting‑edge neuroimaging to improve outcomes for…

Citius Pharmaceuticals, Inc.7h ago

Citius Oncology’s Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe

Data featured in oral presentation at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG)…

Edgewise Therapeutics7h ago

Edgewise Therapeutics Reports Third Quarter 2026 Financial Results

– Published the differentiated mechanism of action of EDG-7500 that targets the regulatory light chain – – Phase 3 trial for EDG-7500 in obstructive…

Tenaya Therapeutics, Inc.7h ago

Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Received Regenerative Medicine Advanced Therapy (RMAT) Designation from U.S. FDA for TN-401 Gene Therapy for PKP2-Associated Arrhythmogenic Right…

GRAIL, Inc.8h ago

GRAIL Reports Third Quarter 2026 Financial Results

FDA Advisory Committee Voted in Favor of Approval of GRAIL's Galleri Multi-Cancer Early Detection Test Q3 Galleri®Test Volume Increased ~24% to More…

Citius Oncology, Inc.8h ago

Citius Oncology’s Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma

Presented at Premier Global CLTG Congress in Europe

NNB Nutrition8h ago

NNB Nutrition Showcased Next-Generation Sweeteners, Naturally Occurring Dipeptides, Ultra-Pure Creatine and Fermented Actives at SupplySide Global 2026

Ingredient innovator launched SweetVantage® with stevia Reb M9 and brazzein and the VasoRush™ dipeptide complex, and showcased its latest innovations…

Relay Therapeutics, Inc.8h ago

Relay Therapeutics, Inc.

Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates

Design Therapeutics, Inc.8h ago

Design Therapeutics Announces Third Quarter 2026 Financial Results and Recent Business Updates

DT-216P2 Anticipated Milestones: Registrational Plan Update in Q4 2026 and 12-Week RESTORE-FA Data in Q1 2027

Immunogenesis Inc.11h ago

ImmunoGenesis to Present IND-Enabling Development Progress and Therapeutic Potential of IMGS-203, a Novel STING Agonist, at SITC 2026 Annual Meeting

ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced upcoming presentations…

Lupus Foundation of America, Inc.11h ago

Lupus Foundation of America Showcases New Research Advancing Lupus Diagnosis and Care at American College of Rheumatology Convergence 2026

Studies highlight persistent challenges in lupus diagnosis and access to specialty care, while advancing more inclusive approaches to research and…

Agency Skin11h ago

Agency Skin™ Introduces Peptide Renewal Hand Cream™, With Clinical Testing Showing Hydration for Up to 100 Hours

New patent-pending formula maintained hydration after a single application as participants continued their normal routines, including handwashing SAN…

Actinium Pharmaceuticals, Inc.14h ago

Actinium Pharmaceuticals Announces ASH 2026 Abstract Highlighting Long-Term Results of Actimab-A in Combination with CLAG-M in Relapsed or Refractory AML

Results report the safety of combining targeted alpha therapy with CLAG-M for patients with relapsed or refractory acute myeloid leukemia Long-term…

BioMarin Pharmaceutical Inc.14h ago

BioMarin to Participate in Upcoming Investor Conferences

Stifel Healthcare Conference, November 11 at 3:20 pm EST UBS Global Biopharma Conference, November 16 at 9:20 am GMT Jefferies Global Healthcare…

Florida Cancer Specialists & Research Institute14h ago

Florida Cancer Specialists & Research Institute Wins Global Gold MarCom Award for 2025 Year in Review Report

Florida Cancer Specialists & Research Institute, LLC (FCS) has been recognized as a Gold Award Winner by the MarCom Awards for the content and design…

TuHURA Biosciences, Inc.14h ago

TuHURA Biosciences Announces Three Presentations at the 68th American Society of Hematology Annual Meeting and Exposition

Presentations highlight the role of the Delta Opioid Receptor (DOR) as a novel target central to the regulation of multiple genes involved in immune…

Lunit15h ago